Experience

Molekule Consulting LLC

• United States
• Business Consulting and Services
• 1 - 100 Employee

• Associate Director

  • Apr 2022 - Present

• Senior Engagement Manager

  • Apr 2021 - Apr 2022

• Engagement Manager

  • May 2020 - Apr 2021

• Senior Consultant

  • Jul 2019 - May 2020

• Consultant

  • Jun 2018 - Jul 2019



Value Edge

• Business Consulting and Services

• Deputy Manager

  • Jan 2017 - Jun 2018

• Senior Analyst

  • Feb 2016 - Jan 2017

  1. Strategic Analysis of ImmunotherapiesIn-depth analysis of the Immune-oncology developments and providing detailed reports/ suggestions regarding strategic positioning of immunotherapies across oncology2.Competitive Insight Analysis of Novel MoAsMonthly tracking of Direct/ Indirect competitors of novel early phase assets across oncology & detailed reports visualizing the evolving landscapeDevelopment of TPPs based on current trends in target indications3.Client Interaction & SupportOn the go support for the Non-Financial Value Addition/ Early Phase Asset Development teams of a big pharma company4.Conference Coverage & Primary InteractionDetailed coverage of sessions/ presentations at international conferences & interaction with key scientific/ industry opinion leaders Show less



Smart analyst India pvt Ltd.

• Research Analyst

  • Sep 2014 - Jan 2016

  Healthcare life science consultant specializing in oncology 1. Clinical Development Timelines across Oncology (Solid tumors) Analysis of Approved and pipeline agents across solid tumors in terms of their clinical development starting from phase I to approval 2. Combination therapy opportunity analysis Identified various opportunities in Oncology for a specific drug combination using scientific rationale, market size, time to market and competitive intensity as filters for prioritization 3. Tumor Knowledge Resource Development Developed a comprehensive report for Bladder Cancer & Prostate Cancer which included: Epidemiology, Risk factors, Current tests available, current treatment algorithm, current treatment landscape, emerging treatment landscape, Pricing & cost effectiveness and biomarker segmentation within the indication 4. Drug positioning within Prostate Cancer: Suggested go/ no-go for positioning of a drug within prostate cancer by analyzing key differentiators: Efficacy, safety, Viability of Mechanism of Action & Strength of Scientific Rationale 5. Training & Tool creation: Working closely with the programming team to create an automated pipeline updating tool Created an excel based tool for easy launch date calculation Trained colleagues to easily identify, quantify (for epidemiology purposes) and interpret data regarding biomarker status (mutation, amplification etc) in tumors Show less



ACTREC

• India
• Research
• 300 - 400 Employee

• Junior Research Fellow (project staff)

  • May 2013 - Sep 2014

  In vitro assay development, DNA/RNA? protein extraction, Gel electrophoresis and western Blotting, HTS, Free Radical generation and Detection, Flow Cytometry, Comet assay. In vitro assay development, DNA/RNA? protein extraction, Gel electrophoresis and western Blotting, HTS, Free Radical generation and Detection, Flow Cytometry, Comet assay.



Preclinical Oncology, Queens Medical College, Nottingham

• Project fellow

  • Feb 2012 - Sep 2012

  Cytotoxicity studies, siRNA silencing, qRT-PCR, Gel electrophoresis and western Blotting, Microscopy, Tissue Culture Cytotoxicity studies, siRNA silencing, qRT-PCR, Gel electrophoresis and western Blotting, Microscopy, Tissue Culture



Nicholas Piramal India Ltd

• Project Trainee

  • Jan 2011 - May 2011

  Cytotoxicity studies, Gel electrophoresis and western Blotting, Microscopy, Tissue Culture, Microscopy, Scientific Writing, High throughput Screening Cytotoxicity studies, Gel electrophoresis and western Blotting, Microscopy, Tissue Culture, Microscopy, Scientific Writing, High throughput Screening